Friday, November 13, 2026
26.4 C
Bengaluru

Pharma GCCs in India — Hype, Reality & What’s Next?

Part 1: Pharma GCCs in India — Orange Markets of Nagpur?

One has to travel to Nagpur and see for oneself the Orange Markets, as I did every month during my days as the Area Sales Head for Western India. The sheer size, quantity and variety and colors are astounding. Nagpur is also known as the "Orange City". So when I read a LinkedIn post likening Pharma GCCs to Nagpur Orange Market, it really caught my attention and ignited my nostalgia for the sweet memories of the difficult to navigate orange markets of Nagpur. Santra has many meanings in Indian lingo. But that's atopic for another day.

Coming to Pharma GCCs, for years now, the Global Capability Center (GCC) phenomenon has been sold as India’s next big growth engine. From industry associations pushing the FDI story to advisory firms monetizing “India setup strategies,” the optics have been perfect. But for pharma service providers, the reality is a little less exciting.

The Pain Points That Haven’t Gone Away

Free Membership Required

You must be a Free member to access this content.

Join Now

Already a member? Log in here

Hot this week

Evonile Pharma: The Real Bet Is Not the Acquisition. It is the Field Force.

ChrysCapital’s acquisition of Novartis India and its transformation into...

Closing the Value Gap in Indian Pharma: What Doctors Really Want from Digital Engagement

Indian pharma is investing heavily in digital engagement. But...

Indian Pharma 2026: The Growth Engine Is Changing

The Indian Pharmaceutical Market isn't just growing. Its centre...

Anand Shetty Appointed CEO – Emerging Markets at Cadila Pharmaceuticals

Cadila Pharmaceuticals has appointed Anand Shetty as Chief Executive...

The paradox of the “Pharmacy of the World.” 💊

India has world-scale formulation capability, yet the chemistry beneath...

Topics

Evonile Pharma: The Real Bet Is Not the Acquisition. It is the Field Force.

ChrysCapital’s acquisition of Novartis India and its transformation into...

Indian Pharma 2026: The Growth Engine Is Changing

The Indian Pharmaceutical Market isn't just growing. Its centre...

Anand Shetty Appointed CEO – Emerging Markets at Cadila Pharmaceuticals

Cadila Pharmaceuticals has appointed Anand Shetty as Chief Executive...

The paradox of the “Pharmacy of the World.” 💊

India has world-scale formulation capability, yet the chemistry beneath...

The Innovator’s Gene and the Generic’s Promise

A medicine must first be discovered. It must then...

Private Equity in Indian Healthcare: Who Is Investing Beyond the Metros?

Private capital is transforming India's healthcare landscape. But is...
spot_img

Related Articles

spot_imgspot_img